Question 1

What specific types of T cell malignancies does this treatment target?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies clinical trial (NCT04828174). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this CAR-T therapy compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies clinical trial (NCT04828174). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of this therapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies clinical trial (NCT04828174). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies clinical trial (NCT04828174). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I do not respond to this therapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies clinical trial (NCT04828174). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks associated with the procedure to collect my cells for this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies clinical trial (NCT04828174). Contact the study team or your healthcare provider for specific answers.

What this study is about